Alcohol septal ablation

From WikiMD's WELLNESSPEDIA

Alcohol septal ablation is a minimally invasive treatment procedure used to manage the symptoms of hypertrophic cardiomyopathy (HCM), a condition characterized by the thickening of the heart muscle. The procedure involves the injection of alcohol into the septal artery, leading to a controlled heart attack that reduces the thickness of the heart muscle.

Procedure[edit]

The procedure is performed by a cardiologist in a catheterization laboratory. The patient is sedated, and a catheter is inserted into the femoral artery in the groin. The catheter is then guided to the heart using fluoroscopy, a type of X-ray imaging. Once the catheter reaches the septal artery, a small amount of alcohol is injected. This causes a controlled heart attack, which leads to the death of the thickened heart muscle cells. Over time, the dead cells are replaced by scar tissue, which reduces the thickness of the heart muscle and improves the symptoms of HCM.

Indications[edit]

Alcohol septal ablation is indicated for patients with hypertrophic cardiomyopathy who have severe symptoms that are not adequately controlled by medication. It may also be considered for patients who are not suitable candidates for septal myectomy, a more invasive surgical procedure.

Risks and Complications[edit]

As with any medical procedure, alcohol septal ablation carries some risks. These include the risk of infection, bleeding, damage to the heart or blood vessels, and the possibility of an irregular heart rhythm. In rare cases, the procedure can lead to a heart block, which may require the implantation of a pacemaker.

Effectiveness[edit]

Studies have shown that alcohol septal ablation can significantly improve symptoms in patients with hypertrophic cardiomyopathy. However, it may not be as effective as septal myectomy in reducing the thickness of the heart muscle.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.